RxDoctor Payments Data

Ryan Miyamoto, MD

Sports Medicine · Fairfax, VANPI 1497923288

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (32.9%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.0%. Reporting peaked in 2022 at $7,842 and has fallen 76.8% since, to $1,816 in 2025.

$19,284in general payments, 2019–2025

Across 146 payments — averaging $132.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orthofix Medical, Inc.$4K
  • Smith+Nephew$3K
  • Supreme Orthopedic Systems, LLC$3K
  • Arthrex$3K
  • Zimmer Biomet$2K
  • Stryker$2K
  • plus $2K from 17 others
$2,233in research payments, 2019–2025

Across 2 payments — averaging $1116.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Orthofix Medical, Inc.$2K

What the payments were for

  • Consulting fees$3,64319%
  • Speaking & faculty fees$1,2506%
  • Travel & lodging$4,25922%
  • Food & beverage$6,34933%
  • Education$3,46518%
  • Other$3182%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,284 in reported general payments places this provider in the 75th percentile of 171 sports medicine providers in Virginia.

See all sports medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$275,441
Medicare patients
517
Services billed
6,443

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium28$337
Methylprednisolone35$284
Cyclobenzaprine Hcl19$167
Tramadol Hcl22$64
Gabapentin11$62
Meloxicam41$31

Paid to pharmacies, not to this prescriber.

Other sports medicine in Fairfax

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →